Vaxxas Publication in PLoS Medicine Reveals Groundbreaking Clinical Research on Broad Potential of Novel High-Density Microarray Patch (HD-MAP)

To Effeciently Deliver Vaccines Directly to the Skin, Enhancing Immunogenicity

Read the full media release below.

Learn more

Posted in — Media Release


You may also like

03 August 2020

KiRA Biotech appoints Global Pharma Business Leader as Independent Board Chair

18 October 2016

Data published in Cancer Medicine Demostrate Clinical Genomics’ Blood Test for Colorectal Cancer Recurrence is Two-Fold More Sensitive than CEA Test

29 May 2020

Vaxxas announces that MSD exercises option to apply novel immune system activation platform for vaccine candidate

15 November 2020

Clinical Genomics Announces Medicare Coverage Applicable to COLVERA® (Liquid Biopsy Test to Detect Recurrence of Colorectal Cancer)

28 May 2020

Harro Höfliger and Vaxxas announce alliance to develop industrial‐scale aseptic processing line for vaccine products based on Vaxxas’ High Density Microarray Patch (HD‐MAP)

19 October 2021

Blade Therapeutics Initiates Additional Phase 1 Clinical Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor